Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fenretinide by Laurent Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
Fenretinide is under clinical development by Laurent Pharmaceuticals and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...
Fenretinide by SciTech Development for Cutaneous T-Cell Lymphoma: Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Cutaneous T-Cell Lymphoma. According to GlobalData,...
Fenretinide by SciTech Development for Sezary Syndrome: Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Sezary Syndrome. According to GlobalData, Phase...
Fenretinide by SciTech Development for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...
Fenretinide by SciTech Development for Mycosis Fungoides: Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase...
Fenretinide by SciTech Development for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Anaplastic Large Cell Lymphoma (ALCL). According...
Fenretinide by SciTech Development for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Fenretinide is under clinical development by SciTech Development and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...